Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy

Severe side effects often restrict clinical application of the widely used chemotherapeutic drug doxorubicin. In order to decrease required substance concentrations, new concepts for successful combination therapy are needed. Since doxorubicin causes DNA damage, combination with compounds that modul...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Death Dis
Main Authors: Pfitzer, Lisa, Moser, Christina, Gegenfurtner, Florian, Arner, Anja, Foerster, Florian, Atzberger, Carina, Zisis, Themistoklis, Kubisch-Dohmen, Rebekka, Busse, Johanna, Smith, Rebecca, Timinszky, Gyula, Kalinina, Olga V., Müller, Rolf, Wagner, Ernst, Vollmar, Angelika M., Zahler, Stefan
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447524/
https://ncbi.nlm.nih.gov/pubmed/30944311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-1546-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares